By-health saw the highest growth of 49% in patent filings in October and 199% in grants in November in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 49% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of By-health’s patent filings and grants. Buy the databook here.
By-health has been focused on protecting inventions in South Korea(KR) with one publication in Q4 2023
The South Korea(KR) Patent Office dominates the patent filings and grants with nearly . The South Korea(KR) patent Office are among the top ten patent offices where By-health is filings its patents. Among the top granted patent authorities, By-health has 100% of its grants in South Korea(KR)
Patents related to rare diseases and health & wellness lead By-health's portfolio
By-health has the highest number of patents in rare diseases followed by, health & wellness and meat & seafood alternatives. For rare diseases, nearly 100% of patents were filed and no patents were granted in Q4 2023.
Food related patents lead By-health portfolio followed by confectionery, and fermented milk
By-health has highest number of patents in food followed by confectionery, fermented milk, non-alcoholic beverages, and concentrates.
For comprehensive analysis of By-health's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.